Covance appoints Kim Yong-kyun as president of Korea's business unit

Published: 2007-11-23 06:56:00

Updated: 2007-11-23 06:56:00

Covance Inc., one of the world's largest and most comprehensive drug development services companies, has announced the appointment of Kim Yong-kyun as president for Korean Operation effective December 1.

Kim majored in medical science at Dsseldorf Medical School from Germany. He joined Pharmac...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK